Hepatitis B Persists In Senegal Due To Untimely Vaccinations, Treatment Costs, Lack Of Screening

IRIN: Hepatitis B — a silent emergency in Senegal
“More than two million people in Senegal, or some 15 percent of the population, including 350,000 chronic carriers, have hepatitis B as a result of untimely vaccinations, prohibitive treatment costs, and lack of universal screening to curb transmissions…” (5/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.